Researchers have redesigned a common chemotherapy drug into a spherical nucleic acid (SNA), dramatically increasing its potency by 20,000 times. This innovative nanomedicine approach targets cancer ...
By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward ...
(Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced the formation of a newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback